Skip to Main Content

As a new year beckons, there is considerable anticipation that many drug makers will vigorously lift a self-imposed moratorium on price hikes that began last summer in response to political pressure from President Trump. After all, the pharmaceutical industry traditionally boosts prices in January in order to meet financial goals. Moreover, White House efforts to staunch rising drug costs have yielded few gains.

Already, a few companies have signaled higher prices are coming, but what might these look like?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.